The first successful transplants of insulin-producing cells in people with type 1 diabetes occurred about 25 years ago. In recent years, advances once considered hypothetical, such as creating and ...
Some simple planning and small adjustments can help your CGM stay connected. Positioning, application and adhesion tips can assist in keeping sensors in place and avoiding skin irritation. Online ...
Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, ...
Off-label use of medications like Ozempic, Wegovy, Mounjaro, and Zepbound is becoming increasingly common to address weight management, insulin resistance, and diabetes related complications in type 1 ...
For people with type 2 diabetes whose glucose levels remain high despite lifestyle changes and treatments like insulin and GLP-1s, screening for excess cortisol may help uncover an often-overlooked ...
GLP-1-based medications have revolutionized blood sugar and weight management, but they aren’t effective for everyone. Eli Lilly, which makes the GLP-1/GIP drug Mounjaro (tirzepatide), is currently ...
A guide to deciding, starting, affording, and living with the most talked-about diabetes medications in a generation. From someone who takes one. Let me guess how you got here. You asked Google or a ...
Stelo by Dexcom is the first over-the-counter continuous glucose monitor (CGM) in the U.S. Though specifically designed for people with prediabetes or type 2 diabetes who don’t use insulin, anyone 18 ...
Type 1 diabetes screening checks for diabetes-related autoantibodies, markers that can show the autoimmune process has started before symptoms appear. Identifying type 1 early can give families time ...
Many important molecules in the body are peptides. Some peptides, like GLP-1, can be modified into effective medications for a variety of conditions, including diabetes. Recently, health, wellness, ...
With so many things happening in the diabetes tech world, it can be hard to keep up. Stay up to date here with the latest diabetes tech news and alerts. At the American Diabetes Association's 2026 ...
Automated insulin delivery (AID) systems have been traditionally used by people with type 1 diabetes but are now more widely available for those with type 2 diabetes after the approval of several ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results